VQS
NASDAQVIQ Solutions Inc.
Website
News25/Ratings1
Latest news
25 items- SECSEC Form 15-12G filed by VIQ Solutions Inc.15-12G - VIQ Solutions Inc. (0001777765) (Filer)
- SECSEC Form 6-K filed by VIQ Solutions Inc.6-K - VIQ Solutions Inc. (0001777765) (Filer)
- SECSEC Form EFFECT filed by VIQ Solutions Inc.EFFECT - VIQ Solutions Inc. (0001777765) (Filer)
- NEWSHC Wainwright & Co. Maintains Buy on VIQ Solns, Lowers Price Target to $0.5HC Wainwright & Co. analyst Scott Buck maintains VIQ Solns (NASDAQ:VQS) with a Buy and lowers the price target from $1 to $0.5.
- SECSEC Form POS AM filed by VIQ Solutions Inc.POS AM - VIQ Solutions Inc. (0001777765) (Filer)
- SECSEC Form S-8 POS filed by VIQ Solutions Inc.S-8 POS - VIQ Solutions Inc. (0001777765) (Filer)
- SECSEC Form 6-K filed by VIQ Solutions Inc.6-K - VIQ Solutions Inc. (0001777765) (Filer)
- SECSEC Form 6-K filed by VIQ Solutions Inc.6-K - VIQ Solutions Inc. (0001777765) (Filer)
- SECSEC Form 6-K filed by VIQ Solutions Inc.6-K - VIQ Solutions Inc. (0001777765) (Filer)
- SECSEC Form 6-K filed by VIQ Solutions Inc.6-K - VIQ Solutions Inc. (0001777765) (Filer)
- SECSEC Form 25-NSE filed by VIQ Solutions Inc.25-NSE - VIQ Solutions Inc. (0001777765) (Subject)
- NEWSWhy Cal-Maine Foods Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionGainers Gaucho Group Holdings, Inc. (NASDAQ:VINO) jumped 95.2% to $3.7280. Gaucho Group is planning to list two of its retail properties in Argentina, in San Rafael and Cordoba, for sale, priced at $2 million and $0.7 million respectively. Vivos Therapeutics, Inc. (NASDAQ:VVOS) shares climbed 73.6% to $0.3230 after the company announced it executed strategic agreements with Ormco and On Demand Orthodontist to provide Spark Clear Aligners to its national network of providers. Conduit Pharmaceuticals Inc. (NASDAQ:CDT) shares climbed 39.7% to $6.72. Histogen Inc. (NASDAQ:HSTO) gained 27% to $0.6350. Pixelworks, Inc. (NASDAQ:PXLW) gained 22% to $1.3100 after reporting preliminary revenue r
- NEWSWhy Brooge Energy Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving PremarketGainers Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) shares rose 72.4% to $0.2930 in pre-market trading after falling 15% on Tuesday. Brainstorm Cell Therapeutics recently announced the FDA Advisory Committee voted that NurOwn did not demonstrate substantial evidence of effectiveness for treatment of mild to moderate ALS. Sonendo, Inc. (NYSE:SONX) shares gained 38% to $0.4416 in pre-market trading after dipping over 55% on Tuesday. Sonendo recently revealed receipt of notice of non-compliance with NYSE trading share price listing rule. Senti Biosciences, Inc. (NASDAQ:SNTI) shares rose 29.8% to $0.5205 in pre-market trading after falling around 7% on Tuesday. Senti Biosciences recen
- NEWSWhy Getty Images Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionGainers Vericity, Inc. (NASDAQ:VERY) shares climbed 87.4% to $11.12 after iA Financial Group announced it will acquire the company. POINT Biopharma Global Inc. (NASDAQ:PNT) surged 84.7% to $12.35. Eli Lilly And Co (NYSE:LLY) agreed to acquire POINT Biopharma Global at $12.50 per share in cash, an aggregate of approximately $1.4 billion. ALX Oncology Holdings Inc. (NASDAQ:ALXO) shares jumped 56% to $7.50 after the company released interim Phase 2 data from its ASPEN-06 trial of evorpacept in advanced HER2-positive gastric cancer. SeaStar Medical Holding Corporation (NASDAQ:ICU) gained 53.3% to $0.6398 after jumping 58% on Monday. SeaStar Medical was recently granted Breakthrough Device
- NEWSWhat's Going On With VIQ Solutions Stock?VIQ Solutions Inc. (NASDAQ:VQS) shares are trading higher Tuesday, though the stock remains more than 20% down over the last month. What To Know: Last Wednesday, VIQ Solutions announced the delisting of its stock from the Nasdaq and the resignation of its director. Shares of VQS are being delisted due to continued failure to satisfy the $1.00 minimum bid price listing requirement in Nasdaq Listing Rule 5550(a)(2). Shares of VQS are up on heavy trading volume Wednesday. According to data from Benzinga Pro, more than 27.5 million shares have been traded in the session, far exceeding the stock's 100-day average of less than 125 thousand shares traded. VIQ Solutions is currently listed as o
- NEWSWhy Delta Apparel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving PremarketGainers VIQ Solutions Inc. (NASDAQ:VQS) shares rose 88.5% to $0.2470 in pre-market trading after falling 18% on Monday. VIQ Solutions recently announced delisting from the Nasdaq. Molekule Group, Inc. (NASDAQ:MKUL) shares gained 31.4% to $0.1960 in pre-market trading. AgileThought, Inc. (NASDAQ:AGIL) shares rose 28.8% to $0.2060 in pre-market trading after gaining 9% on Monday. ALX Oncology Holdings Inc. (NASDAQ:ALXO) shares rose 26.8% to $6.10 in pre-market trading. ALX Oncology Holdings is scheduled to host an investor call and webcast on Oct. 3 to share interim Phase 2 ASPEN-06 clinical trial results of evorpacept for the treatment of advanced HER2-positive gastric cancer. SIGNA Sp
- NEWSVIQ Solutions shares are trading lower after the company announced delisting from the Nasdaq.
- SECSEC Form 6-K filed by VIQ Solutions Inc.6-K - VIQ Solutions Inc. (0001777765) (Filer)
- PRVIQ Solutions Announces Delisting from Nasdaq and Director ResignationVIQ Solutions Inc. ("VIQ" or the "Company") (NASDAQ:VQS), a global provider of secure, AI-driven, digital voice and video capture technology and transcription services, today announced that pursuant to its press release of September 30, 2022 announcing receipt of the initial notice of deficiency from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq"), the Company received a final delisting notice from Nasdaq on September 26, 2023 due to the continued failure to satisfy the $1.00 minimum bid price listing requirement in Nasdaq Listing Rule 5550(a)(2). The Company notified Nasdaq that it would not appeal Nasdaq's delisting decision. Nasdaq has notified the Company
- NEWSAlliance Global Partners Maintains Buy Rating for VIQ Solns: Here's What You Need To KnowAlliance Global Partners has decided to maintain its Buy rating of VIQ Solns (NASDAQ:VQS) and lower its price target from $1.25 to $0.50. Shares of VIQ Solns are trading down 4.17% over the last 24 hours, at $0.20 per share. A move to $0.50 would account for a 146.82% increase from the current share price. About VIQ Solns VIQ Solutions Inc operates as a technology and service platform provider for digital evidence capture, retrieval, and content management in Australia, the United Kingdom, Canada, the United States, and internationally. The reportable segments of the company are technology and related revenue which develops, distributes, and licenses computer-based digital solutions, and the
- NEWSAlliance Global Partners Maintains Buy on VIQ Solns, Lowers Price Target to $0.5Alliance Global Partners analyst Brian Kinstlinger maintains VIQ Solns (NASDAQ:VQS) with a Buy and lowers the price target from $1.25 to $0.5.
- NEWSHC Wainwright & Co. Reiterates Buy on VIQ Solns, Maintains $1 Price TargetHC Wainwright & Co. analyst Scott Buck reiterates VIQ Solns (NASDAQ:VQS) with a Buy and maintains $1 price target.
- SECSEC Form D filed by VIQ Solutions Inc.D - VIQ Solutions Inc. (0001777765) (Filer)
- SECSEC Form 6-K filed by VIQ Solutions Inc.6-K - VIQ Solutions Inc. (0001777765) (Filer)
- PRVIQ Solutions Announces Second Quarter 2023 Financial ResultsVIQ Solutions Inc. ("VIQ" or the "Company") (NASDAQ:VQS), a global provider of secure, AI-driven, digital voice and video capture technology and transcription services, today announces its unaudited financial results for the second quarter ending June 30, 2023. Results are reported in US dollars and prepared in accordance with International Financial Reporting Standards ("IFRS"). "Revenue for the second quarter ending June 30, 2023, grew by 5% sequentially from the previous quarter despite some delays in ramping up of new contracts. When normalized to consider the 50% reduction of the Queensland contract from a year ago and negative foreign exchange impact due to the declining Australian